Publications by authors named "V M Braga"
Article Synopsis
- Cannabidiol (CBD) shows promise in treating cardiovascular issues related to neurodegenerative diseases and has previously shown benefits in reducing blood pressure and oxidative stress in acute studies.
- This study aimed to evaluate the long-term effects of chronic CBD treatment specifically on rats with renovascular hypertension induced by a surgical model.
- Results indicated that chronic CBD significantly lowered blood pressure, improved vascular function, and reduced harmful reactive oxygen species, suggesting its potential as a therapeutic option for cardiovascular problems in hypertension.*
Unlabelled: The remaining filling material after retreatment can harbor bacteria and organic tissues that can influence the outcome of the therapy.
Aim: The aim of this study was to evalúate, by micro-CT, the amount of filling material remaining in the root canal after its removal using WaveOne Gold or ProDesign RT.
Material And Method: Forty human mandibular canines were instrumented with the ProTaper Next system up to the X2 instrument (25.
This study aimed to evaluate effective treatment strategies for laboratory waste with an initial pH of 1.0, containing Cr, Mn, Co, Fe, Ni, Cu, Zn, Sr, Hg, and Pb ions, focusing on flocculation, precipitation, and adsorption techniques. The study utilized microparticles derived from Moringa oleifera seed husks (MS), cryogels of carboxymethyl cellulose (CMC), and hybrid cryogels combining CMC and MS (CMC-MS25 and CMC-MS50) as adsorbents.
View Article and Find Full Text PDFBackground: Optimization of sequential and combination treatment is crucial in shaping long-term management of postmenopausal osteoporosis (OP).
Methods: We conducted a 6-month prospective observational study on postmenopausal women with severe OP receiving treatment with romosozumab either alone (in patients naïve to treatment) or in combination with ongoing long-term denosumab (>2 years) or continuing ongoing denosumab alone (>2 years). We collected serum samples for bone turnover markers, bone modulators, and calcium phosphate metabolism at baseline, month 3 and month 6.